Variants of CARD15 are associated with an aggressive clinical course of Crohn's disease - An IG-IBD study

American Journal of Gastroenterology

Volumn 100, Issue 1, 2005, Pages 84-92

  Annese, Vito ^a   Lombardi, Giovanni ^b   Perri, Francesco ^b   D'Incà, Renata ^b   Ardizzone, Sandro ^b   Riegler, Gabriele ^b   Giaccari, Stelio ^b   Vecchi, Maurizio ^b   Castiglione, Fabiana ^b   Gionchetti, Paolo ^b   Cocchiara, Elena ^b   Vigneri, Sergio ^b   Latiano, Anna ^b   Palmieri, Orazio ^b   Andriulli, Angelo ^b  

^a CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15; FUNGUS ANTIBODY; NEUTROPHIL CYTOPLASMIC ANTIBODY; PROTEIN SACCHAROMYCES CEREVISIAE ANTIBODY; UNCLASSIFIED DRUG; CARD15 PROTEIN, HUMAN; SIGNAL PEPTIDE;

ADULT; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CROHN DISEASE; DISEASE COURSE; DISEASE PREDISPOSITION; DISEASE SEVERITY; ENTERITIS; FAMILY HISTORY; FEMALE; FISTULA; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; STENOSIS; ULCERATIVE COLITIS; CASE CONTROL STUDY; FOLLOW UP; GENE FREQUENCY; GENETICS; ITALY; MIDDLE AGED; MUTATION; PHENOTYPE;

ADULT; CASE-CONTROL STUDIES; COLITIS, ULCERATIVE; CROHN DISEASE; FEMALE; FOLLOW-UP STUDIES; GENE FREQUENCY; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; ITALY; MALE; MIDDLE AGED; MUTATION; NOD2 SIGNALING ADAPTOR PROTEIN; PHENOTYPE;

EID: 13744264167     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2005.40705.x     Document Type: Article

References (49)

1. Bonen DK, Cho J. The genetics of inflammatory bowel disease. Gastroenterology 2002;124:521-36.
2. Zheng CQ, Hu GZ, Zeng ZS, et al. Progress in searching for susceptibility gene for inflammatory bowel disease by positional cloning. World J Gastroenterol 2003;9:1646-56.
3. Annese V, Latiano A, Andriulli A. Genetics of IBD. The beginning of the end or the end of the beginning. Dig Liv Dis 2003;35:442-9.
4. Hugot JP, Chamaillard M, Zouali H, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001;411:599-603.
5. Ogura Y, Bonen DK, Inohara N, et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 2001;411:603-6.
6. Hampe J, Cuthbert A, Croucher PJP, et al. Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations. Lancet 2001;357:1925-8.
7. Lesage S, Zouali H, Cezard JP. CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease. Am J Hum Genet 2002;70:845-57.
8. Girardin SE, Boneca IG, Viala J, et al. NOD2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J Biol Chem 2002;278:8869-72.
9. Ahmad T, Armuzzi A, Bunce M, et al. The molecular classification of the clinical manifestation of Crohn's disease. Gastroenterology 2003;122:854-66.
10. Leong RW, Armuzzi A, Ahmad T, et al. NOD2/CARD15 gene polymorphism and Crohn's disease in the Chinese population. Aliment Pharmacol Ther 2003;17:1465-70.
11. Cuthbert AP, Fisher SA, Mirza M, et al. The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel disease. Gastroenterology 2002;122:867-74.
12. Hampe J, Grebe J, Nikolaus S, et al. Association of NOD2 (CARD15) genotype with clinical course of Crohn's disease: A cohort study. Lancet 2002;359:1661-5.
13. Radlmayr M, Torok HP, Martin K, et al. The c-insertion mutation of the NOD2 gene is associated with fistulizing and fibrostenosing phenotypes in Crohn's disease. (letter). Gastroenterology 2002;122:2091-2.
14. Vermeire S, Wild G, Kocher K, et al. CARD15 gene variation in a Quebec population: Prevalence, genotype-phenotype relationship, and haplotype structure. Am J Hum Genet 2002;71:74-83.
15. Abreu MT, Taylor KD, Lin YC, et al. Mutations in NOD2 are associated with fibrostenosing disease in patients with Crohn's disease. Gastroenterology 2002;123:679-88.
16. Murrillo L, Crusiius JB, van Bodegraven AA, et al. CARD15 gene and the classification of Crohn's disease. Immunogenetics 2002;54:59-61.
17. Helio T, Halme L, Lappalainen M, et al. CARD15/NOD2 gene variants are associated with family occurring and complicated forms of Crohn's disease. Gut 2003;52:558-62.
18. Brant SR, Picco MF, Achkar JP, et al. Defining complex contributions of NOD2/CARD15 gene mutations, age at onset, and tobacco use on Crohn's disease phenotypes. Inflamm Bowel Dis 2003;9:281-9.
19. Fidder HH, Olschwang S, Avidan B, et al. Association between mutations in the CARD15 (NOD2) gene and Crohn's disease in Israeli Jewish patients. Am J Med Genet 2003;121A:240-4.
20. Bairead E, Harmon DL, Curtis AM, et al. Association of NOD2 with Crohn's disease in homogenous Irish population. Eur J Hum Genet 2003;11:237-44.
21. Linskens RK, Mallant-Hent RC, Murillo LS, et al. Genetic and serological markers to identify phenotypic subgroups in a Dutch Crohn's disease population. Dig Liver Dis 2004;36:29-34.
22. Mow WS, Vasiliauskas EA, Lin YC, et al. Association of antibody to microbial antigens and complications of small bowel Crohn's disease. Gastroenterology 2004;126:414-24.
23. Walker LJ, Aldhous MC, Drummond HE, et al. Anti-Saccharomyces cerevisiae antibodies (ASCA) in Crohn's disease are associated with disease severity but not NOD2/CARD15 mutations. Clin Exp Immunol 2004;135:490-6.
24. Giachino D, Van Duist MM, Regazzoni S, et al. Analysis of the CARD15 variants R702W, G908R and L1007fs in Italian IBD patients. Eur J Hum Genet 2004;12:206-12.
25. Vavassori P, Borgiani P, Biancone L, et al. CARD15 mutation analysis in an Italian population: Leu1007fsinsC but neither Arg702Trp, nor Gly908Arg mutations are associated with Crohn's disease. Inflamm Bowel Dis 2004;10:116-21.
26. Mendoza JL, Murillo LS, Fernandez L, et al. Prevalence of mutations of the NOD2/CARD15 gene and relation to phenotype in Spanish patients with Crohn disease. Scand J Gastroenterol 2003;38:1235-40.
27. Heresbach D, Gicquel-Douabin V, Birebent B, et al. NOD/CARD15 gene polymorphism in Crohn's disease: A genotype-phenotype analysis. Eur J Gastroenterol Hepatol 2004;16:55-62.
28. Andriulli A, Annese V, Latiano A, et al. The frame-shift mutation of the NOD2/CARD15 gene is significantly increased in ulcerative colitis. An *IG-IBD study. Gastroenterology, 2004:126:625-7.
29. Linde K, Boor PP, Houwing-Duistermatt JJ, et al. CARD15 and Crohn's disease: Healthy homozygous carriers of the 3020insc frame-shift mutation. Am J Gastroenterol 2003;98:613-7.
30. Annese V, Palmieri O, Latiano A, et al. Frequency of NOD2/CARD15 variants in both sporadic and familial cases of Crohn's disease across Italy. An Italian Group for Inflammatory Bowed Disease study. Dig Liver Dis 2004;36:121-4.
31. Podolsky DK. Inflammatory bowel disease. New Engl J Med 2002;347:417-29.
32. Gasche C, Scholmerich J, Brynskov J, et al. A simple classification of Crohn's disease: Report of a working party of the World Congress of Gastroenterology, Vienna 1998. Inflamm Bowel Dis 2000;6:8-15.
33. Annese V, Andreoli A, Andriulli A, et al. Familial expression of anti-Saccharomyces cerevisiae mannan antibodies in Crohn's disease and ulcerative colitis. A GISC study. Am J Gastroenterol 2001;96:2407-12.
34. Lombardi G, Annese V, Piepoli A, et al. Antineutrophil cytoplasmic antibodies in inflammatory bowel disease: Clinical role and review of the literature. Dis Colon Rectum 2000;43:999-1007.
35. Palmieri O, Toth S, Ferraris A, et al. CARD15 genotyping in inflammatory bowel disease patients by multiplex pyrosequencing. Clin Chem 2003;49:1675-9.
36. Annese V, Latiano A, Palmieri O, et al. Linkage of ulcerative colitis to the pericentromeric region of chromosome 16 in Italian inflammatory bowel disease families is independent of the presence of common CARD15 mutations. J Med Genet 2003;40:837-41.
37. Ogura Y, Imohara N, Benito A, et al. NOD2, a NOD1/Apaf1 family member that is restricted to monocytes and activates NF-kB. J Biol Chem 2001;276:4812-8.
38. Chamailard M, Philpott D, Girardin S, et al. Gene-environment interaction modulated by allelic heterogeneity in inflammatory bowel diseases. Proc Natl Acad Sci U S A 2003;100:3455-60.
39. Bouma G, Strober W. The immunological and genetic basis of inflammatory bowel disease. Nat Rev 2003;3:521-33.
40. Inoue N, Tamura K, Kinouchi Y, et al. Lack of common NOD2 variants in Japanese patients with Crohn's disease. Gastroenterology 2002;123:86-91.
41. Yamazaki K, Takazoe M, Tanaka T, et al. Absence of mutation in the NOD2/CARD15 gene among 483 Japanese patients with Crohn's disease. J Hum Genet 2002;47:469-72.
42. Croucher PJP, Mascheretti S, Hampe J, et al. Haplotype structure and associations to Crohn's disease of CARDl5 mutations in two ethnically divergent populations. Eur J Hum Genet 2003;11:6-16.
43. Reumaux D, Sendid B, Poulain D, et al. Serological marker in inflammatory bowel diseases. Best Pract Res Clin Gastroenterol 2003;17:19-35.
44. Hisamatsu T, Suzuki M, Reinecker HC, et al. CARD15/NOD2 functions as an antibacterial factor in human intestinal epithelial cells. Gastroenterology 2003;124:993-1000.
45. Ogura Y, Lala S, Xin W, et al. Expression of NOD2 in Paneth cells: A possible link to Crohn's ileitis. Gut 2003;52:1591-7.
46. Lala S, Ogura Y, Osborne C, et al. Crohn's disease and the NOD2 gene: A role of Paneth cells. Gastroenterology 2003;125:45-7.
47. Rosenstile P, Fantini M, Brautigam K, et al. TNF-alfa and INF-gamma regulate the expression of the NOD2 (CARD15) gene in human intestinal epithelial cells. Gastroenterology 2003;124:1001-9.
48. Gutierrez O, Pipaon C, Inohara N, et al. Induction of NOD2 in myelomonocytic and intestinal epithelials cells via nuclear factor-kappa B activation. J Biol Chem 2002;277:41701-5.
49. Berrebi D, Maudinas R, Hugot JP, et al. CARD15 gene over-expression in mononuclear and epithelial cells of the inflamed Crohn's disease colon. Gut 2003;52:840-6.